HDAC9 and cancer: This implies that inhibitors of DNA methylation such as 5-aza-2-deoxycytidine and Histone deacetylase (HDAC) inhibitors, alone or in combination with chemotherapy or immunotherapy regimens may have therapeutic potential in HPV-induced cancers.